Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension

Pediatric Cardiology

Volumn 29, Issue 3, 2008, Pages 580-584

  Assadi, Farahnak ^a  

^a Rush Children's Hospital and Rush University Medical Center   (United States)

Author keywords

C Reactive protein; Essential hypertension; Left ventricular hypertrophy; Microalbuminuria

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ANALYSIS OF COVARIANCE; ARTICLE; BODY MASS; CHILD; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIPLE LINEAR REGRESSION ANALYSIS; PEDIATRICS; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ALBUMINURIA; C-REACTIVE PROTEIN; CHILD; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE;

EID: 43549104937     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-007-9153-4     Document Type: Article

References (33)

1. Assadi F (2002) Quantitation of microalbuminuria using random urine samples. Pediatr Nephrol 17:107-110
2. Assadi F (2006) Effect of microalbuminuria-lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatric Cardiol 28:27-33
3. Assadi F (2007) C-reactive protein and incident left ventricular hypertrophy in essential hypertension. Pediatr Cardiol 28:280-285
4. Briars GL, Bailey BG (1994) Surface area estimation: pocket calculator versus nomogram. Arch Dis Child 70:246-247
5. Cole Tj, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. Br Med J 320:1240-1243
6. Daniels SR, Loggie JM, Khoury P, Kimball TR (1998) Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97:1907-1911
7. Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA (1995) Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 76:699-701
8. Daniels SR, Kimball TR, Morrison JA, Khoury P, Witt S, Meyer RA (1995) Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents: Statistical, biological, and clinical significance. Circulation 92:3249-3254
9. Devereux RB, Alonso DR, Lutas EM, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necroscopy findings. Am J Cardiol 57:450-458
10. de Simone G, Daniels SR, Devereux RB, et al. (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251-1260
11. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056-1062
12. De Zeeuw (2004) Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Kidney Int 66(Suppl 92):S2-S6
13. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Inflammation and microalbuminuria in non diabetic and type 2 diabetic subjects: the insulin resistance atherosclerosis study. Kidney Int 58:1703-1710
14. Grandi AM, Santillo R, Bertolini A, et al. (2001) Microalbuminuria as a marker of preclinical diastolic dysfunction in never treated essential hypertensives. Am J Hypertens 14:644-648
15. Herbert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NS Jr, Rovin BH (2001) Renoprotection: one or many therapies? Kidney Int 59:1211-1226
16. Jensen JS, Feldt-Rasmussen BO, Strandgaard S, Schroll M, Borch-Johnson K (2000) Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 35:898-903
17. Keane WF, Eknoyan G (1999) Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 33:1004-1110
18. Litwin M, Niemirska A, Sladowska J, et al. (2006) Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 21:811-819
19. Mattman A, Eintracht S, Mock T, et al. (2006) Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. J Am Soc Nephrol 17:485-496
20. Nakamura M, Onoda T, Itai K, et al.A (2004) Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Int Med 43:919-925
21. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children, Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
22. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R (2002) Centers for Disease Control and Prevention 2000 growth charts for the united States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60
23. Pannacciulli N, Cantatore FP, Minenna M, Bellacicco M, Giorgino R, De Pergola G (2001) Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. J Int Med 250:502-507
24. Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813-1818
25. Ramaswamy P, Lytrivi ID, Paul C, Golden M, Kupferman JC (2007) Regression of left ventricular hypertrophy in children with antihypertensive therapy. Pediatr Nephrol 22:141-143
26. Ridker PM, Cannon CP, Morrow D, et al. (2005) C-Reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20-28
27. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843
28. Rutter Mk, Meigs JB, Sullivan LM, D'Agostina RB Sr, Wilson PW (2004) C-Reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation 110:380-385
29. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) Predicting glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 106:522-526
30. Sorof J, Alexandrov AV, Garami Z, Turner JL, Grafe RE, Lai DL (2003) Carotid ultrasonography for detection of vascular abnormalities in hypertensive children. Pediatr Nephrol 18:1020-1024
31. Stuveling EM, Hillege HL, Bakker SJL et al. PREVEND Study Group (2004) C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. Atherosclerosis 172:107-114
32. Tsioufis C, Dimitriadis K, Chatzis D, et al. (2005) Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in man with essential hypertension. Am J Cardiol 96:946-951
33. Viberti G, Wheeldon NM (2002) Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure independent effect. Circulation 106:672-678